Published Date : 2024-Aug-26
The self-monitoring blood glucose (SMBG) devices market has seen significant growth over the past decade, driven by the rising prevalence of diabetes, increased health awareness, and technological advancements. Several companies are at the forefront of this market, offering innovative solutions that cater to the growing demand for accurate, user-friendly, and reliable blood glucose monitoring devices. Below, we explore some of the top companies leading the SMBG market, highlighting their contributions and key products.
In this blog, we explore some of the top companies in the self-monitoring blood glucose devices market, including Roche Diabetes Care, Abbott Laboratories, Medtronic, Dexcom, Ascensia Diabetes Care, LifeScan, and more.
Self-Monitoring Blood Glucose Devices Market Size, Share & Trends Analysis Report By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast Till 2028.
Global Self-Monitoring Blood Glucose Devices Market size was valued at US$ 11233.43 Million in 2021 and is projected to reach US$ 28323.53 Million by 2028, growing at a CAGR of 12.87% from 2021 to 2028
The Self-Monitoring Blood Glucose Devices market research report comprises a thorough examination of the current and future scenario of this industry vertical. The research highlights major trends and opportunities, as well as challenges, for various segments and sub-segments, while broadening the company horizon. The study report also includes extensive information based on past and present patterns across several industry verticals to help find various expansion prospects. Throughout the forecast period, several estimations regarding market share, market size, and industry growth rate are presented. The research includes information on competitive analysis as well as consumption habits and pricing strategies depending on the Self-Monitoring Blood Glucose Devices market.
The SMBG market is poised for continued growth as more people around the world seek effective ways to manage diabetes. Innovation in sensor technology, smartphone integration, and data analytics are expected to drive the next wave of advancements in this market. Companies that can combine accuracy, convenience, and affordability will likely dominate the SMBG landscape in the coming years.
Overview: Roche is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. The company headquarters is in Basel, Switzerland and founded in 1896.
The company’s flagship product line, Accu-Chek, offers a range of blood glucose meters that are known for their accuracy and ease of use. Roche continues to innovate with features like Bluetooth connectivity, mobile apps integration, and continuous glucose monitoring (CGM) systems that enhance user experience and diabetes management.
Key Products: Accu-Chek Guide, Accu-Chek Instant, Accu-Chek Aviva
Overview: Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States and founded in 1888.
is a prominent player in the medical devices market, particularly known for its FreeStyle line of glucose monitoring products. Abbott’s FreeStyle Libre, a CGM system, has revolutionized the market by providing users with real-time glucose readings without the need for routine finger pricks. This product has been a game-changer, especially for people with Type 1 diabetes, offering convenience and improved glucose control.
Key Products: FreeStyle Libre, FreeStyle Lite
Overview: Medtronic is an American Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Dublin, Ireland and founded in 1949. It operates in more than 150 countries and employs over 90,000 people.
The company is another major player in the diabetes care market, with a strong focus on integrated diabetes management systems. While Medtronic is best known for its insulin pumps, the company also offers advanced CGM systems that work in tandem with its insulin delivery devices. Medtronic’s devices are highly regarded for their precision, real-time data analytics, and the ability to provide predictive alerts to prevent hyperglycemia or hypoglycemia.
Key Products: Guardian Connect, MiniMed 670G System
Overview: Dexcom is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California and founded in 1999.
The company is a market leader in CGM technology, offering devices that provide continuous glucose readings with high accuracy. The company’s G-series CGM systems are popular among both Type 1 and Type 2 diabetes patients. Dexcom has focused on enhancing user experience by developing devices with longer sensor wear time, seamless smartphone integration, and minimal calibration requirements.
Key Products: Dexcom G7, Dexcom G6
Overview: Ascensia Diabetes Care Swiss continuous glucose monitoring (CGM) systems for diabetes equipment manufacturers company. Founded in 2015, the company is headquarters in Basel, Switzerland. The company and products are sold in more than 125 countries worldwide.
The company has established itself as a significant player in the SMBG market. The company’s Contour series of blood glucose meters are known for their reliability and user-friendly design. Ascensia continues to innovate with products that cater to both personal and professional diabetes management.
Key Products: CONTOUR™NEXT Blood Glucose Monitoring Systems, Eversense® Continuous Glucose Monitoring System, Diabetes Management Solutions
Overview: LifeScan, is a diagnostic systems manufacturer company with products focusing on the diabetes market, specifically blood glucose monitoring systems. Founded in 1981, the company is headquartered in Switzerland.
The company is a subsidiary of Johnson & Johnson, is known for its OneTouch brand of blood glucose monitoring devices. The OneTouch products are designed for simplicity and accuracy, making them popular among a wide range of diabetes patients. LifeScan also offers digital health solutions that help users track and manage their glucose levels more effectively.
Key Products: OneTouch Verio Reflect, OneTouch Select Plus
By Product |
|
By Application |
|
By Distribution channel |
|
By Region |
|
The self-monitoring blood glucose devices market is highly competitive, with several companies leading the charge in innovation and user satisfaction. Roche, Abbott, Medtronic, Dexcom, Ascensia, LifeScan, and ARKRAY are among the top players that have set the standard in this industry. As technology continues to evolve, these companies are expected to introduce even more sophisticated products that will make diabetes management easier and more effective for millions of people worldwide.
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, Aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
IMIR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Mr. Smit Patel
Phone: +1 (814) 487 8486
Email: smit@intellectualmarketinsights.com
Corporate Sales: sales@intellectualmarketinsights.com
